Literature DB >> 28940536

Patient value: Perspectives from the advocacy community.

Bonnie J Addario1, Ana Fadich2, Jesme Fox3, Linda Krebs4, Deborah Maskens5, Kathy Oliver6, Erin Schwartz7, Gilliosa Spurrier-Bernard8, Timothy Turnham9.   

Abstract

All health-care systems are under financial pressure and many have therefore developed value frameworks to assist decision making regarding access to treatment. Unfortunately, many frameworks simply reflect the clinically focused values held by health-care professionals rather than outcomes that also matter to patients. It is difficult to define one single homogeneous set of patient values as these are shaped by social, religious and cultural factors, and health-care environment, as well as many factors such as age, gender, education, family and friends and personal finances. Instead of focusing on an aggregated set of values, frameworks should attempt to incorporate the broader range of outcomes that patients may regard as more relevant. Patient advocates are well placed to advise assessment bodies on how particular therapies will impact the patient population under consideration and should be closely involved in developing value frameworks. In this paper, a group of patient advocates explore the varying definitions of patient value and make positive recommendations for working together to strengthen the patient voice in this area. The authors call on framework developers, the patient advocacy and research communities, the health-care industry and decision-makers to undertake specific actions to ensure patient value is included in current and future value frameworks. This is justified on compassionate and economic grounds: better health outcomes result when patients receive treatment tailored to individual needs. Paying attention to the patient perspective also results in better use of resources-a goal that should appeal to all stakeholders.
© 2017 The Authors Health Expectations Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  patient-derived preferences; patient-relevant values; patient-reported outcomes; value frameworks

Mesh:

Year:  2017        PMID: 28940536      PMCID: PMC5750698          DOI: 10.1111/hex.12628

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  1 in total

Review 1.  Patient value: Perspectives from the advocacy community.

Authors:  Bonnie J Addario; Ana Fadich; Jesme Fox; Linda Krebs; Deborah Maskens; Kathy Oliver; Erin Schwartz; Gilliosa Spurrier-Bernard; Timothy Turnham
Journal:  Health Expect       Date:  2017-09-20       Impact factor: 3.377

  1 in total
  11 in total

1.  The Utility of Patient Engagement in Drug Research and Development.

Authors:  Avani Patel; Daniel Fiebig; Juliette Muszka
Journal:  Pharmaceut Med       Date:  2021-05-25

2.  The emancipation of patients: a theory whose time has come.

Authors:  Charlotte Williamson
Journal:  Br J Gen Pract       Date:  2019-03       Impact factor: 5.386

3.  Putting Patients at the Centre of Healthcare: Progress and Challenges for Health Technology Assessments.

Authors:  Karen M Facey; Nicola Bedlington; Sarah Berglas; Neil Bertelsen; Ann N V Single; Victoria Thomas
Journal:  Patient       Date:  2018-12       Impact factor: 3.883

4.  Patient-Centered Core Impact Sets: What They are and Why We Need Them.

Authors:  Eleanor M Perfetto; Elisabeth M Oehrlein; T Rosie Love; Silke Schoch; Annie Kennedy; Jennifer Bright
Journal:  Patient       Date:  2022-06-02       Impact factor: 3.481

Review 5.  Patient value: Perspectives from the advocacy community.

Authors:  Bonnie J Addario; Ana Fadich; Jesme Fox; Linda Krebs; Deborah Maskens; Kathy Oliver; Erin Schwartz; Gilliosa Spurrier-Bernard; Timothy Turnham
Journal:  Health Expect       Date:  2017-09-20       Impact factor: 3.377

6.  The promise of Immuno-oncology: implications for defining the value of cancer treatment.

Authors:  Howard L Kaufman; Michael B Atkins; Prasun Subedi; James Wu; James Chambers; T Joseph Mattingly; Jonathan D Campbell; Jeff Allen; Andrea E Ferris; Richard L Schilsky; Daniel Danielson; J Leonard Lichtenfeld; Linda House; Wendy K D Selig
Journal:  J Immunother Cancer       Date:  2019-05-17       Impact factor: 13.751

Review 7.  Including the patient voice in the development and implementation of patient-reported outcomes in cancer clinical trials.

Authors:  Bonnie Addario; Jan Geissler; Marcia K Horn; Linda U Krebs; Deborah Maskens; Kathy Oliver; Ananda Plate; Erin Schwartz; Nicole Willmarth
Journal:  Health Expect       Date:  2019-11-13       Impact factor: 3.377

8.  Involving people affected by a rare condition in shaping future genomic research.

Authors:  Jack S Nunn; Kylie Gwynne; Sarah Gray; Paul Lacaze
Journal:  Res Involv Engagem       Date:  2021-03-15

9.  Hope for "Continued Vitality": Qualitative Study of Adults With Traumatic Brain Injury and Low Mood on Their Rehabilitation.

Authors:  Adora Chui; Katie N Dainty; Bonnie Kirsh; Deirdre R Dawson; Heather Colquhoun
Journal:  Front Rehabil Sci       Date:  2022-02-22

10.  Patient and Payer Preferences for Additional Value Criteria.

Authors:  Ivett Jakab; Melanie D Whittington; Elizabeth Franklin; Susan Raiola; Jonathan D Campbell; Zoltán Kaló; R Brett McQueen
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.